Inhibition of CASC9 upregulates the phosphorylation level of AMPK and suppresses Akt-mTOR signaling, inhibiting tumor growth and inducing autophagy in HCT116 and SW480 human CRC cells, which is a promising strategy for CRC therapy (50). The gene discussed is MTOR; the disease is neoplasm.